Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 514Leukemia 340Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Myelodysplastic Syndromes 235Lymphoma, Non-Hodgkin 173Lymphoma 162Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Hematologic Neoplasms 133Multiple Myeloma 121Lymphoma, Follicular 120Lymphoma, Large B-Cell, Diffuse 119Lymphoma, Mantle-Cell 118Recurrence 115Hodgkin Disease 99Burkitt Lymphoma 99Lymphoma, B-Cell, Marginal Zone 98Leukemia, Myelomonocytic, Chronic 78Congenital Abnormalities 78Leukemia, Myeloid, Chronic-Phase 68Neoplasms 67Myeloproliferative Disorders 66Lymphoma, Large-Cell, Immunoblastic 64Blast Crisis 59Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 57Waldenstrom Macroglobulinemia 53Primary Myelofibrosis 53Lymphoma, T-Cell, Cutaneous 52Leukemia, Myeloid, Accelerated Phase 50Neoplasms, Plasma Cell 48

Interventions

SARS-CoV-2 inactivated vaccines 1Lenalidomide 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Agammaglobulinemia × Other hematologic neoplasm × Clear all
NCT01924169 2018-09-20

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 7 charts
LymphoidOther hematologic neoplasm

Agammaglobulinemia, Hematologic Diseases, Influenza, Human, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡